Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 214

1.

Prenatal exposure to antidepressants and language competence at age three: results from a large population-based pregnancy cohort in Norway.

Skurtveit S, Selmer R, Roth C, Hernandez-Diaz S, Handal M.

BJOG. 2014 Dec;121(13):1621-31. doi: 10.1111/1471-0528.12821. Epub 2014 Apr 14.

2.

Motor development in children prenatally exposed to selective serotonin reuptake inhibitors: a large population-based pregnancy cohort study.

Handal M, Skurtveit S, Furu K, Hernandez-Diaz S, Skovlund E, Nystad W, Selmer R.

BJOG. 2016 Nov;123(12):1908-1917. doi: 10.1111/1471-0528.13582. Epub 2015 Sep 15.

3.

Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.

Brown AS, Gyllenberg D, Malm H, McKeague IW, Hinkka-Yli-Salomäki S, Artama M, Gissler M, Cheslack-Postava K, Weissman MM, Gingrich JA, Sourander A.

JAMA Psychiatry. 2016 Nov 1;73(11):1163-1170. doi: 10.1001/jamapsychiatry.2016.2594.

PMID:
27732704
4.

Prenatal exposure to selective serotonin reuptake inhibitors and childhood overweight at 7 years of age.

Grzeskowiak LE, Gilbert AL, Sørensen TI, Olsen J, Sørensen HT, Pedersen LH, Morrison JL.

Ann Epidemiol. 2013 Nov;23(11):681-7. doi: 10.1016/j.annepidem.2013.08.005. Epub 2013 Oct 7.

PMID:
24113367
5.

Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.

Nulman I, Koren G, Rovet J, Barrera M, Pulver A, Streiner D, Feldman B.

Am J Psychiatry. 2012 Nov;169(11):1165-74. doi: 10.1176/appi.ajp.2012.11111721.

PMID:
23128923
6.

Prenatal effects of selective serotonin reuptake inhibitor antidepressants, serotonin transporter promoter genotype (SLC6A4), and maternal mood on child behavior at 3 years of age.

Oberlander TF, Papsdorf M, Brain UM, Misri S, Ross C, Grunau RE.

Arch Pediatr Adolesc Med. 2010 May;164(5):444-51. doi: 10.1001/archpediatrics.2010.51.

PMID:
20439795
7.

Maternal dietary exposure to dioxins and polychlorinated biphenyls (PCBs) is associated with language delay in 3year old Norwegian children.

Caspersen IH, Haugen M, Schjølberg S, Vejrup K, Knutsen HK, Brantsæter AL, Meltzer HM, Alexander J, Magnus P, Kvalem HE.

Environ Int. 2016 May;91:180-7. doi: 10.1016/j.envint.2016.02.031. Epub 2016 Mar 9.

PMID:
26970589
8.

Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitors: a population-based study in Western Australia.

Colvin L, Slack-Smith L, Stanley FJ, Bower C.

CNS Drugs. 2012 Jul 1;26(7):e1-14. doi: 10.2165/11634190-000000000-00000.

9.

No association between prenatal exposure to psychotropics and intelligence at age five.

Eriksen HL, Kesmodel US, Pedersen LH, Mortensen EL.

Acta Obstet Gynecol Scand. 2015 May;94(5):501-7. doi: 10.1111/aogs.12611. Epub 2015 Mar 17.

PMID:
25711407
10.

Prenatal Exposure to Folic Acid and Antidepressants and Language Development: A Population-Based Cohort Study.

Handal M, Skurtveit S, Roth C, Hernandez-Diaz S, Selmer R.

J Clin Psychopharmacol. 2016 Aug;36(4):333-9. doi: 10.1097/JCP.0000000000000519.

PMID:
27285658
11.

A report from #BlueJC: is prozac going to affect my baby's development?

Leung EY.

BJOG. 2015 May;122(6):886. doi: 10.1111/1471-0528.13414. No abstract available.

12.

Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study.

Nordeng H, van Gelder MM, Spigset O, Koren G, Einarson A, Eberhard-Gran M.

J Clin Psychopharmacol. 2012 Apr;32(2):186-94. doi: 10.1097/JCP.0b013e3182490eaf.

PMID:
22367660
13.

Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study.

Nulman I, Rovet J, Stewart DE, Wolpin J, Pace-Asciak P, Shuhaiber S, Koren G.

Am J Psychiatry. 2002 Nov;159(11):1889-95.

PMID:
12411224
14.

Rate of Chiari I malformation in children of mothers with depression with and without prenatal SSRI exposure.

Knickmeyer RC, Meltzer-Brody S, Woolson S, Hamer RM, Smith JK, Lury K, Gilmore JH.

Neuropsychopharmacology. 2014 Oct;39(11):2611-21. doi: 10.1038/npp.2014.114. Epub 2014 May 20.

15.

Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes.

El Marroun H, Jaddoe VW, Hudziak JJ, Roza SJ, Steegers EA, Hofman A, Verhulst FC, White TJ, Stricker BH, Tiemeier H.

Arch Gen Psychiatry. 2012 Jul;69(7):706-14. doi: 10.1001/archgenpsychiatry.2011.2333.

PMID:
22393202
16.

Prenatal exposure to anxiolytics and hypnotics and language competence at 3 years of age.

Odsbu I, Skurtveit S, Selmer R, Roth C, Hernandez-Diaz S, Handal M.

Eur J Clin Pharmacol. 2015 Mar;71(3):283-91. doi: 10.1007/s00228-014-1797-4. Epub 2014 Dec 30.

PMID:
25547568
17.

Behavior and inhibitory control in children with prenatal exposure to antidepressants and medically untreated depression.

Hermansen TK, Røysamb E, Augusti EM, Melinder A.

Psychopharmacology (Berl). 2016 Apr;233(8):1523-35. doi: 10.1007/s00213-016-4248-3. Epub 2016 Feb 29.

PMID:
26924747
19.

Depression and anxiety in women with epilepsy during pregnancy and after delivery: a prospective population-based cohort study on frequency, risk factors, medication, and prognosis.

Bjørk MH, Veiby G, Reiter SC, Berle JØ, Daltveit AK, Spigset O, Engelsen BA, Gilhus NE.

Epilepsia. 2015 Jan;56(1):28-39. doi: 10.1111/epi.12884. Epub 2014 Dec 19.

20.

Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy.

Oberlander TF, Reebye P, Misri S, Papsdorf M, Kim J, Grunau RE.

Arch Pediatr Adolesc Med. 2007 Jan;161(1):22-9.

PMID:
17199063

Supplemental Content

Support Center